Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes! Trading Soon!!! Dazed name change complete
Update- $medh
— the 1 & Only HANS (@The1OnlyHans) February 7, 2024
Name change complete
Dazed=> MedX. #OTC access next.
FINs upload.
Pink Current. pic.twitter.com/kNbKhLOoRB
If Hans were ever indicted then I would believe you.
At this point you are just scared of your own delusion.
“Did I mention we are a publicly traded company. OTC ticker (MEDH)
DM me! Let's talk about a 2M capital raise.”
https://www.linkedin.com/posts/hansenriquez_lfg-consumptionlounge-franchisebusiness-activity-7158817861182914562-4Kl3
When Rockets?
Who/What is this? 72hrs or foreclosure??
Is this the Lazydaze location or something else?
https://www.linkedin.com/posts/hansenriquez_realestate-rei-franchise-activity-7157902188881551361-hp0n
First time I say to pdgood…
The Jeremy Amsden (CNNA) connection is very interesting
Outstanding Shares
703,263,385
What’s with all the dilution?
“As we all know, 2023 was a horrible year for initial public offerings in biotech. However, the IPO market seems to have come alive in early 2024 with five companies jumping into the fray—Alto Neuroscience, ArriVent Biopharma, CG Oncology, Kyverna Therapeutics and Metagenomi.”
When Curative Biotech?
https://www.biospace.com/article/2024-brings-surprising-early-surge-of-biotech-ipos-/
iRobot dumping shares?
Green Day???
Hans is the website just not accurate!
Where is Pasadena, San Marcos, San Antonio locations?
Hans is the website just not accurate!
Where is Pasadena, San Marcos, San Antonio locations?
https://www.lazydazeshop.com/baltimore-maryland
Lazydaze now updated locations. Only two current locations.
1. Austin
2. Albuquerque
3…. Baltimore franchise
Im guessing Hans no longer has San Antonio and San Marcos
Pdgood is a scam artist
Hans need to get ahead of these developments with a current tradeable stock. He is missing out on tradeable "buys" .... all little good news counts
Hang in there bud!
Get current and proper accounting established and we Rocket!
And with all that you said you are still here mocoso
Twofold intent is showing Dr Heah deep with new company Kriya who likes Ophthalmology with same eye indications as CUBT and that they have big money in the bank!
Try and YouTube search: Kriya Therapeutics - Theresa Heah, MD, MBA
Junior Varsity right there!
Curative Biotech should simply post the PR on their X (Twitter) account!
https://www.biospace.com/article/releases/curative-biotechnology-inc-announces-nomination-of-dr-theresa-heah-to-board-of-directors/
CUBT’s Metformin Reformulation targeting the treatment of intermediate and late-stage Age-Related Macular Degeneration (AMD) disease has a goal of being in the clinic in 2024 for a first in human trial of its metformin-based eye drop. The trial will be conducted under a Cooperative Research and Development Agreement (CRADA) with the NEI.
$0.03 imminent
Bring it
Great addition to the BoD. 2024 will be positive!
Better average down now if you’re upside down!
Nickel soon!
Our girl Dr Heah is a biotech beast! She’s awesome
https://www.biotech2050.com/episodes/transforming-medicine-through-non-viral-gene-therapy-theresa-heah-ceo-intergalactic-tx
They are not talking about the new director…
The confusion was the LinkedIn account who Erroneously used curative biotech name and image… when in fact she was working for a different company named Curative (a different company)
They are not talking about the new director…
The confusion was the LinkedIn account who Erroneously used curative biotech name and image… when in fact she was working for a different company named Curative (a different company)
$0.03 to a Nickel!
Big add coming soon…
Get the word out! It will happen…in 2024
$100 mil, new funds will boost Kriya's technology and expand its pipeline, as well as propel assets in oncology, eye diseases and metabolic diseases
They may like CUBT indications …. As they say .. “ Geographic atrophy is an advanced form of dry age-related macular degeneration and uveitis refers to a group of inflammatory diseases that causes swelling in the eye and destroys eye tissues.”
https://www.fiercebiotech.com/biotech/kriya-grabs-100m-to-bankroll-gene-therapies-for-diabetes-other-prevalent-diseases
Dr Heah says she loves creating shareholder value!!!
Let’s get a big win!!!
https://www.outsourcing-pharma.com/Article/2023/06/28/Women-in-Science-Dr.-Theresa-Heah-on-opening-new-frontiers?utm_source=copyright&utm_medium=OnSite&utm_campaign=copyright
Japan network.
Dr. Heah led global ophthalmologic innovation with multiple successful regulatory submissions in the U.S., Europe, and Japan.
https://www.aabdc.com/post/theresa-heah
Garr and Michaels seem to have zero abilities to attract any interest here…
Wonder which one of them is the issue?
Dr. Heah has led multiple successful global ophthalmic innovation, regulatory submissions and commercialization of products including Ozurdex®, EYLEA®, Rhopressa® & Rocklatan.® While at Bayer, she launched EYLEA® successfully into its eventual status as a blockbuster drug.